End-stage renal disease: Measures to prevent it or slow its progression: Postgraduate Medicine: Vol 100, No 5

Views

CrossRef citations to date

Altmetric

Preview

It is no secret that end-stage renal disease from any cause is a costly and debilitating condition. The good news is that in many patients with renal injury, appropriate glycemic control, antihypertensive therapy, and modifications in lifestyle can delay renal failure. In this article, Drs Hood and Gennari recommend specific pharmacologic and dietary measures that can prevent or slow the progression of renal disease, and they emphasize the role of angiotensin-converting enzyme inhibitors in achieving blood pressure control, the main preventive strategy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

End-stage renal disease

Measures to prevent it or slow its progression

Information for

Open access

Opportunities

Help and information

End-stage renal disease

Measures to prevent it or slow its progression

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature